Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
Date:3/3/2010

ges related to product recall(k) 604 - 604 - ------------------------------------------------------------------------- ------------------------------------------------------------------------- Adjusted EBITDA $ 6,868 $ 10,332 $ 49,311 $ 37,109 ------------------------------------------------------------------------- ------------------------------------------------------------------------- RECONCILIATION OF GAAP NET LOSS TO NON-GAAP ADJUSTED NET LOSS (Unaudited) Three months ended Year ended (in thousands December 31, December 31, U.S.$) 2009 2008 2009 2008 ------------- ------------- ------------- ------------- GAAP - net loss (15,633) (76,963) (22,868) (741,176) Non recurring revenue(a) (53) (352) (25,556) (910) Technology acquisition related charge(c) 500 313 1,866 3,438 Non-recurring supply/distribution agreement termination costs(b) - - - 500 Non-recurring restructuring related charges(b) (309) 1,583 3,820 10,407 Stock based compensation expense(d) 408 458 1,579 2,436 Litigation related charges(g) 684 177 3,297 2,670 Write-down of investments, goodwill & other long-lived assets(i) 3,090 62,532 3,090 674,555 Write-down and other deferred financing charges(f) 712 4,224 3,431 19,445 Forei
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Angiotech Pharmaceuticals Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
3. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
4. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
5. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
9. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
10. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... ... August 26, 2015 , ... ... today that a second US laboratory is to open in Manhattan, Kansas in ... continued partnership and long-term growth of research and development through collaboration with researchers ...
(Date:8/26/2015)... 26, 2015  The Diabetes Research Institute (DRI), ... Miami Miller School of Medicine, announced today that ... test for the first time a novel transplant ... FDA approved Phase I/II study builds upon decades ... an important first step toward the development of ...
(Date:8/26/2015)... -- China Cord Blood Corporation (NYSE: CO ) ... of cord blood collection, laboratory testing, hematopoietic stem cell ... the Company has been informed that Magnum Opus 2 ... Mr. Yuen Kam, chairman of the board of directors ... "Shares") of  Excellent China Healthcare Investment Limited ("KKR SPV") ...
(Date:8/26/2015)... (PRWEB) , ... August 26, 2015 , ... The 2015 ... Boston adult stem cell technology start-up company Asymmetrex to share the first ... capabilities of a new biomarker for counting adult tissue stem cells. , With a ...
Breaking Biology Technology:MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 2Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 3Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 4
... to the community and its biotech ... ... LLY ) announced today completion of the final phase of its $1 ... a ceremony at its Indianapolis operations, Lilly officials, along,with participation by Indianapolis ...
... Market Open on Monday, ... May 19th ... a clinical stage pharmaceutical company committed to,discovering, developing and commercializing novel drugs ... to join the,NASDAQ Biotechnology Index effective with the market open on May ...
... will highlight choice of different modalities ... on single integrated imaging platform., SAN DIEGO, and ... ), a leading manufacturer and developer of,intravascular ultrasound (IVUS), ... to enhance the diagnosis and,treatment of coronary and peripheral ...
Cached Biology Technology:Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex 2Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex 3Pharmasset Selected to Join the NASDAQ Biotechnology Index 2Pharmasset Selected to Join the NASDAQ Biotechnology Index 3Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 2Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 3Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 4
(Date:8/20/2015)... Calif. , Aug. 20, 2015 ... on consumers that are active and healthy. However, ... in the hospital environment to help improve diagnostic ... a video from the Wearable Technologies Conference ... discussed new applications for wearables in healthcare.    ...
(Date:8/18/2015)... 18, 2015  Navitas today announced that ... the Submission Content Management webinar scheduled on ... forum. Dedicated to the Implementation of Regulatory Submission ... for industry, vendors, health authorities, consultants and ... towards a standard method of implementing electronic ...
(Date:8/12/2015)... SPRINGS, Florida , August 12, 2015 ... the pace of mobile payment innovation and advanced biometrics ... to replace the way consumers rely on using their ... ahead with reinventing the future for payment services led ... (NASDAQ: NXTD ), :  Google, Inc. (NASDAQ: ...
Breaking Biology News(10 mins):Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6
... is one of the hottest ideas in science but has ... Scientists with the U.S. Department of Energy,s Lawrence Berkeley National ... pearl to create what may well be the toughest ceramic ... water of an aluminum oxide (alumina) and the addition of ...
... the Babraham Institute near Cambridge, supported by the ... Sciences Research Council (BBSRC), have discovered that the ... diseases of ageing such as Alzheimer,s disease. The ... Brain . Alzheimer,s disease causes nerve cells ...
... world,s leading publisher of scientific information, announced today the ... Award. Prof. J J Theo Groothuizen, S&T Counsellor, ... at Le Meridien in New Delhi. The award ... researchers in India who have made significant contributions to ...
Cached Biology News:Scientists create tough ceramic that mimics mother of pearl 2Scientists create tough ceramic that mimics mother of pearl 3Maintaining the brain's wiring in aging and disease 2Elsevier announces winners of 3rd Annual Scopus Young Indian Scientist Award 2
Mouse Anti-Human Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4 Monoclonal Antibody Family: New...
Mouse monoclonal [7B9] to beta II Tubulin ( Abpromise for all tested applications). Antigen: Synthetic peptide, CEEEEGEDEA found at the c-terminus of beta II tubulin. Entrez GeneID: 10383 ...
Gridded Cell Culture Petri Dish (20 mm molded in base), tissue-culture treated...
...
Biology Products: